{"id":"W4414570461","doi":"10.1016/j.leukres.2025.108113","title":"Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemia","year":2025,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Bristol-Myers Squibb","keywords":"Chronic lymphocytic leukemia; Surrogate endpoint; Clinical endpoint; Confidence interval; Randomized controlled trial; Odds ratio; Proportional hazards model","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.03497419,0.002008985,0.006462894,0.00653974,0.0008413622,0.0003951794,0.002830155,0.002858468,0.001847943],"category_scores_gemma":[0.02911349,0.001743326,0.001700799,0.008118455,0.001379108,0.0002704657,0.003248973,0.01061725,0.004694155],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.7596588,"about_ca_system_score_gemma":0.6819965,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006987246,"about_ca_topic_score_gemma":0.0002898685,"domain_scores_codex":[0.9645501,0.01579795,0.004059469,0.004106717,0.006323321,0.005162484],"domain_scores_gemma":[0.9667235,0.02457385,0.0006100945,0.005019257,0.001466773,0.001606547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01154531,0.0001904206,0.000002561156,0.1533583,0.0007728074,0.01215283,0.000528461,0.0007243453,0.001213158,0.0002808395,0.008917097,0.8103139],"study_design_scores_gemma":[0.02981415,0.002343414,0.00001676747,0.1342915,0.0006176597,0.001196475,0.0001504782,0.02999586,0.0001672389,0.0002401371,0.7998713,0.001295026],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01151519,0.968971,0.000007935276,0.0001504603,0.0005616699,0.008868483,0.0001341755,0.0003866195,0.009404426],"genre_scores_gemma":[0.001274321,0.9404885,0.0002778842,0.0001489753,0.0008706784,0.002177898,0.000690692,0.0005145342,0.05355656],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8090189,"threshold_uncertainty_score":0.9996253,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2214576003030156,"score_gpt":0.5080526382068011,"score_spread":0.2865950379037855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}